primary prevention of coeliac disease - Associazione Italiana ...

More documents

Recommendations

Info

40 COELIAC DISEASE IN THE SAHARAWI amplification by the polymerase chain reaction and sequential hybridization to sequence-specific oligonucleotide probes. Immunogenetics 1990; 32: 413-8. 21. Bugawan TL, Erlich HA. Rapid typing of HLA-DQB1 DNA polymorphism using nonradiactive oligonucleotide probes and amplified DNA. Immunogenetics 1991; 33: 163-70. 22. Thomson G. Mapping disease genes: family-based association studies. Am J Hum Genet 1995; 57: 487-98. 23. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134-48. 24. Kruscal, J.B. Multidimensional Scaling by Optimizing Goodness of fit to a Nonmetric Hypothesis. Psychometrika 1964; 29: 1-27. 25. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234-42. 26. Meloni G, Dore A, Fanciulli G, Tanda F, Bottazzo GF. Subclinical coeliac disease in schoolchildren from northern Sardinia. Lancet 1999; 353: 37. 27. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten-sensitivity "celiac sprue". Gastroenterology 1992;102: 330-54. 28. Kerneis S, Chauviere G, Darfeuille-Michaud A, et al. Expression of receptors for enterotoxigenic Escherichia coli during enterocytic differentiation of human polarized intestinal epithelial cells in culture. Infect Immun 1992;60: 2572-80. 29. Rätsch IM, Catassi C. Coeliac disease is a primary, potentially treatable, health problem of Saharawi refugee children. Bulletin of the World Health Organization 2001; 79: 541-5. 30. Arnaiz-Villena A, Benmamar D, Alvarez M, Diaz-Campos N, Varela P, Gomez- Casado, et al. HLA allele and haplotype frequencies in Algerians. Relatedness in Spaniards and Basques. Hum Immunol 1995; 43: 259-68. 31. Ivanova R, Naoumova E, Lepage V, Djoulah S, Yordanov Y, Loste MN et al. HLA- DRB1, DQA1, DQB1 DNA polymorphism in the Bulgarian population. Tissue Antigens 1996; 47: 122-6. 32. Chang YW, Hawkins BR. HLA class I and class II frequencies of a Hong Kong Chinese population based on bone marrow donor registry data. Hum Immunol 2002; 56: 125-35. 33. Fernandez-Viña M, Gao X, Moraes ME, Moraes JR, Salatiel I, Miller et al. Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups. Immunogenetics 1991; 34: 299-312. 34. Arnaiz-Villena, A., Iliakis, P., Gonzalez-Hevilla, M., Longas, J., Gomez-Casado, E., Sfyridaki, K., et al. The origin of Cretan populations as determined by characterization of HLA alleles. Tissue Antigens 1999; 53: 213-26. 35. Cernà,M, Fernandez-Vina M, Ivaskova E. and Stastny P. Comparison of HLA class II alleles in Gypsy and Czech populations by DNA typing with oligonucleotide probes. Tissue Antigens 1992; 39: 111-6. 36. Fort M, de Stefano, G.F., Cambon-Thomsen, A., Giraldo-Alvarez, P., Dugoujon, J.M., Ohayon, E., et al. HLA class II allele and haplotype frequencies in Ethiopian Amhara and Oromo populations. Tissue Antigens 1998; 51: 327-36.
COELIAC DISEASE IN THE SAHARAWI 41 37. Mack SJ, Bugawan TL, Moonsamy PV, Erlich JA, Trachtenberg EA, Paik YK, et al. Evolution of Pacific/Asian populations inferred from HLA class II allele frequency distributions. Tissue Antigens 2000; 55: 383-400. 38. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In, Tsuji, K., Aizawa, M. and Sasazuki, T. eds.:, HLA 1991. Oxford University Press, Oxford, UK, Vol. 1, pp. 1065-1220. 39. Migot-Nabias F, Fajardy I, Danze PM, Everaere S, Mayombo Y, Minh TN, et al. HLA class II polymorphism in a Gabonese Banzabi population. Tissue Antigens 1999; 53: 580-5. 40. Doherty DG, Vaughan RW, Donaldson PT, Mowat AP. HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis, distribution of alleles and haplotypes in British Caucasoids. Hum Immunol 1992; 34: 53-63. 41 Papassavas EC, Spyropoulou-Vlachou M, Papassavas AC, Schipper RF, Doxiadis IN, Stavropoulos-Giokas C. MHC Class I and II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data. Hum Immunol; 61: 615-23. 42. Hashimoto M, Kinoshita T, Yamasaki M, Tanaka H, Imanishi T, Ihara, et al. Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals. Tissue Antigens 2000;44: 166-73. 43. Izaabel H, Garchon HJ, Caillat-Zucman S, Beaurain G, Akhayat O, Bach JF et al. HLA class II DNA polymorphism in a Moroccan population from the Souss, Agadir area. Tissue Antigens 1998; 51: 106-10. 44. Rønningen KS, Spurkland A, Markussen G, Iwe T, Vartdal F, Thorsby E. Distribution of HLA class II alleles among Norwegian Caucasians. Hum Immunol 1990; 29: 275-281. 45. Kapustin S, Lyshchov A, Alexandrova J, Imyanitov E, Blinov M. HLA class II molecular polymorphisms in healthy Slavic individuals from North-Western Russia. Tissue Antigens 1999; 54: 517-520. 46. Gao X, Zimmet P, Serjeantson SW. HLA-DR,DQ sequence polymorphisms in Polynesians, Micronesians, and Javanese. Hum Immunol 1992; 34: 153-161. 47. Hmida S, Gauthier A, Dridi A, Quillivic F, Genetet B, Boukef K. HLA class II gene polymorphism in Tunisians. Tissue Antigens 1995; 45: 63-8. 48. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, Ornek I, Vaughan R. Eraksoy M. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum. Immunol. 1997; 55: 59-65. 49. Lampis R, Morelli L, Congia M, Macis MD, Mulargia A, Loddo M, et al. The interregional distribution of HLA class II haplotypes indicates the suitability of the Sardinian population for case-control association studies in complex diseases. Hum Mol Genet 2000; 9: 2959-65.
Page 1:
Perspectives on Coeliac Disease Vol
Page 4: The AIC Meeting was held in the Aul
Page 8 and 9: Italian Coeliac Society, Via Picott
Page 11 and 12: Preface Coeliac disease (CD) is a u
Page 13: Contents Current understanding of t
Page 16 and 17: 2 THE BASIS OF COELIAC DISEASE hapl
Page 18 and 19: 4 THE BASIS OF COELIAC DISEASE 1 pr
Page 20 and 21: 6 THE BASIS OF COELIAC DISEASE spre
Page 22 and 23: 8 THE BASIS OF COELIAC DISEASE Ackn
Page 24 and 25: 10 THE BASIS OF COELIAC DISEASE glu
Page 27 and 28: Catassi C, Fasano A, Corazza GR (ed
Page 29: T CELL RESPONSES TO GLUTEN PEPTIDES
Page 32 and 33: 18 A DOMINANT EPITOPE IN GLUTEN PEP
Page 42 and 43: 28 ROLE OF A-GLIADIN 31-49 PEPTIDE
Page 47 and 48: COELIAC DISEASE IN THE SAHARAWI 33
Page 53: COELIAC DISEASE IN THE SAHARAWI 39
Page 58 and 59: 44 INFANT FEEDING PRACTICES AND COE
Page 66 and 67: Age (years) 52 INFANT FEEDING PRACT
Page 76 and 77: 62 MECHANISMS OF ORAL TOLERANCE the
Page 78 and 79: 64 MECHANISMS OF ORAL TOLERANCE pot
Page 80 and 81: 66 MECHANISMS OF ORAL TOLERANCE Epi
Page 82 and 83: 68 MECHANISMS OF ORAL TOLERANCE typ
Page 84 and 85: 70 MECHANISMS OF ORAL TOLERANCE 51
Page 86 and 87: 72 MECHANISMS OF ORAL TOLERANCE 23.
Page 91 and 92: GENETICALLY DETOXIFIED GRAINS 77 to
Page 93 and 94: • • GENETICALLY DETOXIFIED GRAI
Page 95 and 96: GENETICALLY DETOXIFIED GRAINS 81 3.
Page 99 and 100: IMMUNOTHERAPY OF COELIAC DISEASE 85
Page 101 and 102: IMMUNOTHERAPY OF COELIAC DISEASE 87
Page 105 and 106:
RECENT ADVANCES ON GLUTEN TOXICITY
Page 107 and 108:
Index A Antiendomysium antibodies (
Page 109:
INDEX 95 W Wheat, 7, 23, 27, 31, 53
show all

primary prevention of coeliac disease - Associazione Italiana ...

Create successful ePaper yourself

Delete template?

Save as template?